| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | -0.00085 | 1 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | 0.0041 | 1 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.00076 | 1 |
| mRNA | RDEA119 | FIMM | pan-cancer | AAC | -0.0038 | 1 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00065 | 1 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | -0.003 | 1 |
| mRNA | NU-7441 | GDSC1000 | pan-cancer | AAC | 0.00056 | 1 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.00056 | 1 |